Guan, Xiuwen
Ma, Fei
Li, Qiao
Chen, Shanshan
Lan, Bo
Fan, Ying
Wang, Jiayu
Luo, Yang
Cai, Ruigang
Zhang, Pin
Li, Qing
Xu, Binghe
Funding for this research was provided by:
National Nature Science Foundation of China (8210114934)
China Postdoctoral Science Foundation (2020M680455)
CAMS Innovation Fund for Medical Sciences (CIFMS, 2021-I2M-1-014)
Article History
Received: 25 September 2022
Accepted: 26 November 2022
First Online: 20 February 2023
Declarations
:
: The study was approved by the Independent Ethics Committee of National Cancer Center / Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College, and the informed consent was signed by each patient before entering the research trials.
: All authors have read and approved the manuscript and agree with submission to <i>Biomarker Research</i>.
: The authors declare that they have no competing interests.